Evman27

Investor DYOR

[Fusion Antibodies @FsnAntibodies]

We've just released the following announcement: Fusion Antibodies - Update on grant-funded DR5 project

Check out the full announcement and join in with the conversation at: https://t.co/0Qc5ZFRxt6

#FAB

[Evman27 @Evman271]

@BreakoutCV #FAB please mate, putting in some strong candles, news soon, Japan patent in the public domain the company should RNS next week among other items, thanks.

[Chris Hutch @MrChrisHutch]

#fab three big news items due, all could add value to the price, starting the Japanese patent that has been officially granted but not reported to market yet.

Assume they are waiting for attorney letter confirming it. But you can check it is there registered. Don’t wait for the rns

#qde #avct #80m #sml #itm #jan #qhe #fum

[Evman27 @Evman271]

@100kDiary Fusion antibodies is an account maker #FAB

[Evman27 @Evman271]

#FAB

Really like the weekly setup here, all indicators suggest a strong few weeks whilst moving into a news rich period.

Weekly slingshot candle now in play, MACD curling, RSI positive, volume picking up. Small float, sticky hands. Certainly one to watch.

DYOR

[Darren-Uk Trading. @Darrenukdaytra1]

#FAB move off the buy zone and it’s cleared the 200ma resistance. Now needs to clear the 50ma to send it higher. Rising 9ma support. Rsi above 50 positive. Rising Macd. Aroon direction positive. Looking good. DYOR

[Evman27 @Evman271]

#FAB

Strong support past 6 months at 12.75p. Tends to sit range bound for months before big upside moves shown by orange candles.

Imminent news on a multitude of fronts, is FAB gearing up for its next move up? 21p is next key target, 28p following to close the historical gap.

[Evman27 @Evman271]

Is the fab group, the most fun chat out there?

Much savage abuse, interspersed with bro love and sheer comedy.

With fantastic investment prospects.

https://t.co/0Xx74nIb42

[Evman27 @Evman271]

@BreakoutCV #FAB for your midweek post please!

[Chris Hutch @MrChrisHutch]

I don’t want anyone complaining when they miss #fab rocket.

You have had 5 business days, two weeks in Hawaii, a dirty weekend in Paris and Christmas since it was mentioned. 😀

[Walbrook PR @WalbrookPR]

🚀@FsnAntibodies - Launch of OptiMAL® platform at the Antibody Engineering and Therapeutics conference in San Diego

➡️Incorporates #FAB's naïve, synthetic library of antibody sequences & the Mammalian Display
📜Protected under US patent with patents pending in other territories

[Evman27 @Evman271]

@investwisely321 @detector_trader Need to seriously look at FAB, 7 years in the making of Optimal and all about to kick off, new streamlined business with a highly competent CEO and team ready to go!

[Fusion Antibodies @FsnAntibodies]

🚀 Fusion Antibodies Deep Dive
Fusion Antibodies (LSE:FAB) is set to launch its OptiMAL Library in December. In this new Deep Dive video, Rick Buick, CSO, explains what makes the Opti Library unique.

Watch the full Deep Dive now. https://t.co/jbdtjqKmn4

#fab

[Evman27 @Evman271]

The latest developments provide us with a more solid foundation with which to address a wider market and positions OptiMAL® as the potential front line discovery platform of choice for human therapeutic antibody discovery."

Looking forward to official commercial launch in Dec!

[Evman27 @Evman271]

Another exciting update from #FAB

Dr. Adrian Kinkaid, CEO of Fusion Antibodies plc, commented: "We are again delighted with the performance of the OptiMAL® platform providing very high affinity antibodies against peptides, a prevalent but challenging target class.

[Walbrook PR @WalbrookPR]

✅@FsnAntibodies #FAB provides an update to the OptiMAL® project with the NCI

✔️ Findings enable #FAB to propose OptiMAL® for a wider range of targets, broadening the accessible market and increasing revenue potential
💡 Company is on track for the commercial launch of OptiMAL®

[💰 𝑺𝒑𝒐𝒏𝒈𝒆 💰 @TheMoneySponge]

@FsnAntibodies #FAB

"However, the NCI has asked to extend its use of the OptiMAL® platform for use against further targets in the coming years. Negotiations are now underway to establish mutually agreeable terms for an extended agreement"

This is a biggie

[Evman27 @Evman271]

@FsnAntibodies A very proud Richard, so he should be!

[Paul warwick @Paulwarwick19]

#FAB the market really hasn't understood how undervalued FaB is. The collaboration to make a DR5 antibody with QUB could on its own create an asset worth £500 million plus. It's the holy grail of antibodies for killing cancer check out the details. Dyor but huge BuY imo

[Evman27 @Evman271]

@TheSaintCharts #FAB Thanks